secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2025-08-19T23:59:59+00:00
Accession:  0000950170-25-110174
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics receives Nasdaq delisting notice over equity non-compliance
-------------------------------------------------------------------------

- Received notice Aug 19, 2025 that as of June 30, 2025 it is non-compliant with Nasdaq Equity Rule 5550(b)(1).
- Trading suspension set for Aug 28, 2025 unless hearing requested by Aug 26; company plans to request stay.
- Subject to Panel Monitor through June 23, 2026; no compliance plan opportunity if non-compliant again.
- Company considering all options but no assurance the Panel will grant continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025110174/0000950170-25-110174-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025110174/hcwb-20250819.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-110174

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer